Osage University Partners Pitch Deck Teardown: Demystifying

Introduction: The VC Perspective on University Spinouts

The presentation titled Venture Capital and Founders' Equity 101 by Osage University Partners (OUP) is not a startup pitch deck in the traditional sense. Instead, it is a pedagogical tool used by Kirsten Leute and John Lee to educate academic founders on the mechanics of the venture capital industry. For a fundraising analyst, this deck is a goldmine of benchmark data, showing exactly how a specialized fund evaluates opportunities and what they expect from founders in terms of equity and team structure.

Slide 1-7: The OUP Mandate and Portfolio

The deck opens by establishing the credibility of the presenters. Kirsten Leute, SVP of University Relations, brings experience from Stanford’s Office of Technology Licensing (Slide 3). This is a critical signal to academic founders that the firm understands the specific nuances of university IP and licensing.

On Slide 5, OUP provides an overview of their fund structure. They manage $315 million in AUM and invest exclusively in startups from 93 partner institutions . The slide details their fund progression: Fund I ($100M, 39 investments), Fund II ($215M, 47 investments, 90% deployed), and a target for Fund III at $250M. This transparency regarding fund life and deployment status is something founders should always look for when researching a VC.

Slide 7 displays an extensive portfolio categorized by stage, from Seed to 4th Round+. Notable names like SiFive, Clarifai, and Biohaven are visible. This slide serves to prove that OUP is stage-agnostic, provided the startup originates from a partner university.

Slide 9-11: The Growth of University Startups

Slide 11 provides a historical bar chart showing the rise of university-launched startups. The data shows a steady climb from 360 startups in 2003 to 1,012 in 2015 . This macro-trend justifies OUP's existence and highlights the increasing importance of academic research as a source of venture-scale deal flow.

Slide 13-15: The Mechanics of a VC Fund

These slides explain the 'plumbing' of venture capital. Slide 13 breaks down the relationship between General Partners (GPs) who manage the fund and Limited Partners (LPs) like insurance companies and endowments who provide the capital. A key takeaway for founders is that GPs are also answerable to their own investors, which dictates their risk tolerance and exit timelines.

Slide 15 is particularly useful for founders to understand the '10 plus 2' year life cycle of a fund. It notes that VCs typically have a 4-year investment period and, crucially, they reserve $2-$3 for every $1 they invest for future rounds. Founders often forget that a VC's initial check is just the beginning; the VC must maintain reserves to avoid dilution in later stages.

Slide 17-19: The Selection Process and Due Diligence

Slide 17 reveals the 'Actual OUP Deal Flow Annualized.' It is a sobering funnel for any founder: 2,000 deals considered leads to 500 meetings, 250 GP reviews, 125 due diligence processes, and finally, 15 funded companies . This represents a 0.75% success rate from initial consideration to funding.

Slide 19 outlines the 'VC Due Diligence Factors.' The hierarchy is clear: CEO and Management Team is the most important factor, followed by Market Opportunity . Technology and IP, while important in a university context, are secondary to the team's ability to execute and the size of the market they are entering.

Slide 23: Pitching Guidelines

The deck offers practical advice for the pitching process on Slide 23. The six core tenets are: Don't Cold Call , Pre-empt 'killer' questions, Make slides visually interesting with sparse text, Be clear and concise, Admit when you don't know an answer, and Do not hide substantive negative information.

Slide 29-31: The Hall of Shame and Bad Investors

In a rare moment of VC candor, Slide 29 shows logos of high-profile failures including Theranos, Solyndra, Webvan, and Napster under the heading 'But Not This.' This serves as a reminder that high valuations and hype do not guarantee success.

Slide 31 balances this by warning founders about 'Bad Venture Investors.' It lists behaviors such as parasitic investing, obstructive behavior, and poor board culture . This reinforces the idea that fundraising is a two-way street; founders must vet their investors as thoroughly as they are being vetted.

Slide 33-39: Equity and Team Evolution

Slide 33 provides a benchmark for the 'Initial Founder Split.' It suggests a lead founder/CEO typically takes 40% , co-founders/employees take 40% , and an option pool takes 20% . It notes that initial lead equity usually ranges from 30-60% . This is one of the most valuable slides in the deck for early-stage founders seeking a baseline for cap table construction.

Slide 35 addresses the 'Scientific Founder.' It acknowledges that professors often return to the university after 1-2 years, and their contribution 'inevitably diminishes.' However, it argues for issuing them options for their role in the 'pipeline of innovation' and student hiring. Slide 37 then explains that most startups turnover their teams 3 times as they move from product development to scale, requiring 'continuously refreshed option pools.'

Finally, Slide 39 provides an 'Equity Distribution Plan' based on Wealthfront data, detailing how grants should be handled for new hires, promotions, outstanding performance, and 'evergreen' grants starting at the 2.5-year anniversary.

Slide 41-43: Capital Needs and Contact

Slide 41 discusses how capital needs vary by industry, citing time between development and market, regulatory barriers, and Capex as major variables. The deck concludes on Slide 43 with direct contact information for Kirsten Leute and John Lee at their Pennsylvania headquarters.

What Works in This Deck

Extreme Transparency: By showing the actual deal funnel (Slide 17) and equity benchmarks (Slide 33), OUP provides founders with realistic expectations rather than vague platitudes. · Focus on the 'Why': The deck explains the incentives of the LPs and GPs (Slide 13), helping founders understand why VCs behave the way they do regarding exit timelines and board seats. · Stage-Specific Advice: The section on Scientific Founders (Slide 35) directly addresses the unique friction point in university spinouts: the transition from lab lead to company founder.

What Is Missing

Specific Exit Data: While Slide 7 mentions 'Exits,' the deck does not provide specific multiples or IRR data for the portfolio, which would further validate their investment strategy. · Diversity and Inclusion Metrics: There is no mention of how OUP approaches diversity in its portfolio or within the university ecosystems it serves. · Post-Investment Support: The deck focuses heavily on the 'getting funded' part of the journey but offers little detail on the specific 'network benefits and programs' mentioned on Slide 5.

What a Founder Should Copy

The Hierarchy of Diligence: Founders should structure their own decks to mirror Slide 19. If the CEO and Team are the most important factors to a VC, that slide should be the strongest and most prominent in the startup's pitch. · Benchmark Awareness: Founders should use the equity splits on Slide 33 as a 'sanity check' for their own cap tables before approaching investors. · The 'Funnel' Mindset: Understanding that a VC only funds 0.75% of what they see should encourage founders to treat fundraising as a high-volume sales process rather than a series of one-off meetings.